WittGen

Seed
wittgenbio.com Biotech & Healthcare United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced May 7, 2026
Investors 1 Backer
Decision Makers 1 Verified

About WittGen

WittGen Biotechnologies utilizes a single-cell RNA sequencing data analysis and testing to overcome the heterogeneity of cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters United States
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website wittgenbio.com
Domain Registered Date Mar 23, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    wittgenbio.com

Investors & Backers

1
Plug and Play

Funding History

2 Rounds
Seed · May 7, 2026
Undisclosed
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

3

Minjun Kim

Founder

Work email & phone locked Unlock →

Minwoo Jung

Co-founder & CTO

Work email & phone locked Unlock →

Yun Rhie

Co-founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts